Related Experiment Video
Updated: May 30, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Symptomatic myocarditis in Kawasaki disease
Pooja Aggarwal1, Deepti Suri, Nidhi Narula
1Division of Allergy Immunology, Department of Pediatrics, Advanced Pediatrics Center, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Kawasaki disease (KD) can rarely cause severe heart failure in children. Methylprednisolone rescue therapy showed prompt recovery in a young boy with acute KD and cardiac failure.
Area of Science:
- Pediatric Cardiology
- Rheumatology
- Immunology
Background:
- Kawasaki disease (KD) is an acute febrile illness causing vasculitis, primarily in children.
- Coronary artery involvement is common, but symptomatic heart failure is rare.
Observation:
- A 9-year-old boy presented with severe heart failure during the acute phase of KD.
- Initial treatment with intravenous immunoglobulin yielded limited clinical improvement.
Findings:
- The patient received 5 daily pulses of intravenous methylprednisolone and oral prednisolone.
- Prompt clinical recovery and sustained well-being were observed following steroid therapy.
Implications:
- Methylprednisolone can be a valuable rescue therapy for acute Kawasaki disease with symptomatic congestive heart failure.
- This case highlights the potential benefit of early steroid intervention in severe KD cardiac manifestations.
Abstract:
Kawasaki disease (KD) is an acute febrile illness of infants and young children that is characterized by a medium vessel vasculitis, most commonly involving the coronary arteries. Though subclinical myocarditis is rather common in KD, symptomatic congestive heart failure is extremely uncommon. The authors report a 9-y-old boy who developed heart failure (ejection fraction 28%) in the acute phase of KD. He was initially treated with intravenous immunoglobulin (2 g/kg) without much clinical improvement. He was then given 5 daily pulses of intravenous methylprednisolone followed by tapering doses of oral prednisolone. The child showed prompt clinical recovery and remains well on follow-up. The present case serves to highlight the fact that methylprednisolone can be considered upfront as rescue therapy in children with KD who have symptomatic congestive cardiac failure during the acute stage of the disease.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Myocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies